This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Wende Niforatos: Innovator in Purinergic Receptor Research
Introduction
Wende Niforatos is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of molecular biology, particularly in the study of purinergic receptors. Her innovative work has led to advancements in understanding human purinoreceptors, which play a crucial role in various physiological processes.
Latest Patents
Wende Niforatos holds a patent for "Nucleic acids encoding a functional human purinoreceptor P2X2 and P2X4, and methods of production and use thereof." This patent encompasses human P2X and P2X purinergic receptor polypeptides. It includes nucleic acid molecules that encode these receptors, as well as vectors and host cells containing such nucleic acids. The patent also outlines methods for producing these receptor polypeptides and their applications in screening for compounds that affect P2X receptors. Furthermore, it contemplates therapeutic uses involving these receptors.
Career Highlights
Wende Niforatos is associated with Abbott Laboratories Corporation, where she has been instrumental in advancing research related to purinergic receptors. Her work has not only contributed to scientific knowledge but also has potential therapeutic implications.
Collaborations
Wende has collaborated with notable colleagues, including Edward C. Burgard and Randy E. Metzger. These collaborations have further enriched her research and expanded the impact of her innovations.
Conclusion
Wende Niforatos is a trailblazer in the field of purinergic receptor research, with a patent that highlights her innovative contributions. Her work at Abbott Laboratories Corporation and collaborations with esteemed colleagues underscore her commitment to advancing scientific understanding and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
